Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

DH - Definitive Healthcare Corp. So'nggi... | Finranks

Home

DH

D

Definitive Healthcare Corp. (DH)

NMS – Real vaqt narxi. Valyuta: USD

1.05

-0.04 (-3.67%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

1.05

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 4:04 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates

Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.08 per share a year ago.

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference.

Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.

Videolar

No Data

There is no data to display

Press-relizlar

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.

Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ: DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market.

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025

FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.